Intuitive Surgical: FY26 Q2 earnings call, Jul 16, 2026
No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jul 16, 2026 earnings call (FY26 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
18 matches for “Ion”; 5 quoted, at least 25 words apart.
…We saw continued global adoption across our MultiPort, da Vinci SP, and Ion platforms and steady execution by our teams. In Q2, total procedures increased…
We placed 468 da Vinci systems and 55 Ion systems in the quarter. Within MultiPort, placements reflected strong adoption of da Vinci 5, including dual…
Turning to Ion, lung cancer diagnosis and time to treatment remain major challenges globally. Customers and policymakers are recognizing the value of our Ion platform,…
Our commercial teams have now installed Ion systems in 12 countries outside the U.S., and our development teams are making strong progress on our ROES…
Our portfolio includes innovative platforms such as SP and Ion, which expand the reach of robotics into new clinical applications, while continued enhancements across our…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-07-16:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP